Concepedia

Publication | Open Access

Optimal dose and schedule of an HER‐2/<i>neu</i> (E75) peptide vaccine to prevent breast cancer recurrence

DOIFull Paper Access

50

Citations

28

References

2008

Year

Jarrod P. Holmes, Jeremy D. Gates, Linda C. Benavides, Matthew T. Hueman, Mark G. Carmichael, Ritesh Patil, Dianna Craig, Elizabeth A. Mittendorf, Alexander Stojadinovic, Sathibalan Ponniah,
Cancer

Abstract

Compared with suboptimally dosed patients, the optimally dosed E75 vaccine in disease-free BCa patients had similar toxicity but enhanced HER-2/neu-specific immunity that may lead to decreased recurrences with additional follow-up.

References

YearCitations

Page 1